Day: November 15, 2022

InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

Written by Customer Service on November 15, 2022. Posted in Earnings Releases And Operating Results.

Eleventh consecutive quarter of sequential profitable revenue growth Annualized revenue run rate of $155 million Adjusted EBITDA1 run rate of $36 million Achieved Run Rate Net Profit of 12$ million Strong balance sheet with $93 million cash supporting future profitable growth NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company”) is pleased to announce its financial and operating results for the third quarter ended September 30, 2022. All amounts are expressed in New Israeli Shekels (NIS) or Canadian dollars ($), unless otherwise noted. Third Quarter 2022 Key Financial & Operating HighlightsRecord revenue of $39 million (NIS 101 million), which represent a 63% growth than the third quarter...

PainReform Provides Business Update for the Third Quarter of 2022

Written by Customer Service on November 15, 2022. Posted in Earnings Releases And Operating Results.

Implements Technology Improvements Related to PRF-110 Manufacturing Process Ahead of Planned Phase 3 Clinical Trial in Bunionectomy TEL AVIV, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the third quarter ended September 30, 2022. Ilan Hadar, Chief Executive Officer of Pain Reform, stated, “We are making steady headway towards commencing the Phase 3 U.S. clinical trial of PRF-110 for post-operative pain relief following bunionectomy surgery. Towards this end, with our CMO in the U.S.A, we implemented a number of enhancements to the manufacturing process. We encountered a requirement for some further work...

SAB Biotherapeutics Provides Company Update for Q3 2022 Financial Results

Written by Customer Service on November 15, 2022. Posted in Earnings Releases And Operating Results.

SIOUX FALLS, S.D., Nov. 15, 2022 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today reported financial results for the third quarter ended September 30, 2022, and provided a company update. “We continue to utilize our capabilities and infrastructure to advance our development pipeline in immunotherapeutics directed at unmet medical needs in respiratory diseases and in gastrointestinal disease with our Clostridioides difficile (C. diff) program and have discovery programs in autoimmune disease and oncology. During the quarter we were able to show data that further validates our platform at targeted medical conferences....

Genius Brands Announces 951% Revenue Growth for the 3rd Quarter of 2022

Written by Customer Service on November 15, 2022. Posted in Earnings Releases And Operating Results.

Synergies Resulting from Acquisitions DrivingRevenue Growth and Continued Margin Improvement Company reports production advancing on 4-year, $39M contract to produce animated series for leading SVOD network and global consumer products company, as well as 7 series in production for leading broadcasters including Netflix, YouTube Kids and elsewhere Kartoon Channel continues growth fueled by brand safety for children Reports solid cash position and expects to turn cash flow positive in 2023 BEVERLY HILLS, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) — Genius Brands International, Inc. (“Genius Brands”) (NASDAQ: GNUS), a global brand management company that creates, produces, broadcasts, and licenses entertainment content for children, today provided a business update and filed its 10Q financial report for the third quarter ended September...

Todos Medical Announces Third Quarter 2022 Financial Results

Written by Customer Service on November 15, 2022. Posted in Earnings Releases And Operating Results.

§ 89% increase in Q3/2022 quarterly revenues as compared with Q3/2021 § Earnings and business update call to be held at 8:30am ET on November 15, 2022 New York, NY, and Tel Aviv, ISRAEL, Nov. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, announced financial results today for the third quarter of 2022, which ended on September 30, 2022. The Company will host a conference call today at 8:30am ET on November 15, 2022. “We achieved key milestones in the third quarter of 2022 to diversify our PCR lab testing revenue and expand the target audience for our dietary supplement business,” said Gerald Commissiong, President & CEO of Todos. “As we move towards the end of the year and prepare for 2023, we believe Todos is well...

VR completes the fall drill program at its Hecla-Kilmer critical metals discovery in Northern Ontario

Written by Customer Service on November 15, 2022. Posted in Public Companies.

Figure 1 Key critical metal intersections from the first 17 drill holes completed at Hecla-Kilmer, and locations of the five new holes completed in October, 2022, all plotted on a contoured RTP magnetic base map with superimposed 3D isoshells from the MVI inversion.Photo 1 Drill core from 391 m in Hole HK22-018 showing cockade prismatic amphibole (green) and biotite (black) crystals up to 1cm in length growing into a phoscorite vein composed of coarse calcite and apatite (pink). The high core angle large crystal growths suggest a near vertical emplacement and extensional open space. NQ core diameter is 36.5 mm.Photo 2 Drill core from 439m depth in the extension of HK22-013 where drilling finished in mineralization last spring. The totally biotite replaced host rock has been brecciated and infilled by a dense network of calcite-apatite...

Victory Square Technologies Corporate Update

Written by Customer Service on November 15, 2022. Posted in Public Companies.

2022 Q3 unaudited Net Asset Value (“NAV”) of $80,701,078 as at September 30, 2022 Change Of Auditor to MNP LLP, Chartered Professional Accountant Notable Portfolio Highlights: IV Hydreight, GameOn, XR Immersive, Stardust Solar, Victory Square Health and more Company & Executive Team featured in Forbes, Entrepreneur, CoinTelegraph and Newsweek Investor Q&A Webinar on Tuesday November 15, 2022VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company focused on investing in the best and brightest entrepreneurs and innovations from around the world, is pleased to provide a corporate update. Shafin Diamond Tejani, CEO of Victory Square: “2022 has been a year of continued growth and new opportunities for Victory...

UFP Technologies, Inc. to Present and Host 1×1 Investor Meetings at the Southwest IDEAS Investor Conference November 16

Written by Customer Service on November 15, 2022. Posted in Public Companies.

NEWBURYPORT, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman & CEO R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate at the Southwest IDEAS Investor Conference on November 16, 2022. UFP Technologies’ presentation is scheduled to begin at 3:00 pm CT on November 16. The presentation will be webcast and can be accessed through the conference site, www.IDEASconferences.com, and in the investor relations section of the company’s website: www.UFPT.com/Investors. About IDEAS Investor Conferences The mission of the IDEAS Conferences is to provide independent regional venues for quality companies to present...

TWO HANDS CORPORATION EXPANDS WITH FOCUS ON SPECIALTY ITALIAN IMPORTS

Written by Customer Service on November 15, 2022. Posted in Public Companies.

Toronto, Ontario, Nov. 15, 2022 (GLOBE NEWSWIRE) — Two Hands Corporation, (CSE: TWOH) (OTC: TWOH) is pleased to announce that it has returned from travels in Italy securing more local Italian partners to expand their product lines available on their leading grocery platform, Gocart.city, with a continued focus on specialty Italian imported grocery products. “With grocery platform sales continuing to rise it’s important to keep differentiating ourselves. We are excited to be expanding with this new line of authentic imported Italian products made in Italy for our diverse customers in the Greater Toronto Area. We will be offering everything from unique pastas, olive oils to panettone for the holiday season.” Nadav Elituv, CEO of Two Hands Corporation. The online grocery trend exploded throughout the pandemic and according to a recent...

CareCloud’s Charts and Central Recognized by Business News Daily for the Best Workflow in Medical Software

Written by Customer Service on November 15, 2022. Posted in Public Companies.

CareCloud’s easy-to-use medical software platform boosts productivity and increases profitability for busy medical practices SOMERSET, N.J., Nov. 15, 2022 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that Business News Daily recognized CareCloud Charts and CareCloud Central as medical software with the best workflow in their list of Best Medical Software of 2022. Central is CareCloud’s modern practice management software that boosts productivity by automating daily tasks that can slow an office manager down. Central can generate cleaner claims, reduce denials, streamline workflows, and deliver robust, real-time analytics through customizable reports and dashboards. Central includes a multi-view calendar...

Day: November 15, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals